• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR

NYRADA INC. - Charts / Financials

0.00% ! 30.0¢
Market Cap $63.43M  !
Healthcare Biotechnology
Add to My Watchlist

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

refresh Created with Sketch. REFRESH
Last update - 15.08pm 08/08/2025 (20 minute delay) ?
Day
Open 30.0¢   Day High 30.0¢   Day Low 29.0¢
Daily Volume 829747
Bids   Sellers
Number Price Volume   Number Price Volume
2 29.5¢ 29101   2 30.0¢ 311729

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
30.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $63.43M
Open High Low Value Volume
30.0¢ 30.0¢ 29.0¢ $245.6K 829.7K

Buyers (Bids)

No. Vol. Price($)
2 29101 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 311729 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
Last
30.0¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
29.5¢ 30.0¢ 29.0¢ 60823
Last updated 15.08pm 08/08/2025 ?

Top Stories

Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history

Dual-listed across the NASDAQ and ASX, Neuren Pharma (ASX:NEU) has jumped +7% down under in the morning Thursday session as...
Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7 Liontown Resources (ASX:LTR) has topped the HotCopper forums today @ and by a wide margin @ after stopping into a trading halt before unveiling a fully underwritten $266 million placement aimed at @fortifying” its finances.Listen to the HotCopper podcast for in-depth discuss...
Lindian jumps 8pc after being awarded full costs as Deep Blue Sea case thrown out The ongoing court case between Lindian Resources (ASX:LIN), Valley Resources Development, and Deep Blue Sea (ASX:DBS) has today been thrown out by the High Court of Malawi with full costs awarded in favour of Lindian.Listen to the HotCopper podcast for in-depth discussions and insights on all the...
Trigg moves into US defence-heavy tungsten space with market reaction mixed Trigg Minerals (ASX:TMG) has unveiled a strategic move into the tungsten market, tracking Almonty Industries' meteoric gains...
Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up Liontown Resources (ASX:LTR) has launched a $266 million fully underwritten placement to reinforce its balance sheet and @ensure a resilient financial footing” as it ramps up activities at its flagship Kathleen Valley Lithium Operation.Listen to the HotCopper podcast for in-...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.